← Open Payments lookup

ABDULLAH MUBARAK: Open Payments

NPI 1336109925 · TYLER, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$110,464 in 173 payments from 11 companies in 2025. Trend: 2023 $30,325 · 2024 $114,991 · 2025 $110,464

Speaker / faculty: $94,012Travel & lodging: $6,445Consulting: $5,470Food & beverage: $4,537
CompanyPaymentsAmount
Madrigal Pharmaceuticals40$30,462
Ipsen Biopharmaceuticals, Inc27$30,415
Gilead Sciences, Inc.54$25,690
ABBVIE INC.29$23,291
Intercept Pharmaceuticals, Inc.12$253
Kerecis Limited2$187
Intra-Sana Laboratories3$60
Novo Nordisk Inc2$37
Mirum Pharmaceuticals, Inc.2$37
Takeda Pharmaceuticals U.S.A., Inc.1$19

Products named: IQIRVO, REZDIFFRA, MAVYRET, Epclusa, Livdelzi, OCALIVA, Kerecis SurgiClose, RELTONE 200 MG.

Industry payments across TX — which companies pay providers there.